Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA purine N7 sites refer to the nitrogen atom at position 7 of the purine ring in guanine and adenine bases within the major groove of double-stranded DNA. This site is highly nucleophilic and sterically accessible, making it the primary target for many classical chemotherapeutic agents, including platinum-based drugs (such as cisplatin, carboplatin, and oxaliplatin) and alkylating agents (such as nitrogen mustards, cyclophosphamide, and temozolomide). Covalent modification or coordination at the N7 position of purines disrupts the DNA double helix structure, forming monoadducts, intrastrand crosslinks, and interstrand crosslinks. These lesions physically block DNA replication and transcription machinery, leading to replication fork collapse, double-strand breaks, and the activation of DNA damage response pathways. Ultimately, the accumulation of unrepaired DNA damage triggers apoptosis, particularly in rapidly proliferating cancer cells. However, because these agents lack specificity for cancer cells, targeting DNA purine N7 sites is associated with significant toxicities, including myelosuppression, nephrotoxicity, and the risk of secondary malignancies due to mutagenic effects in healthy tissues.
Covalent binding or coordination to the nucleophilic N7 position of purine bases (primarily guanine) in DNA, leading to the formation of DNA adducts, intrastrand crosslinks, and interstrand crosslinks. This blocks DNA replication and transcription, triggers the DNA damage response, and induces apoptosis.
13 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA purine N7 sites.